Verona Pharma plc is a biotechnology business based in the US. Verona Pharma shares (VRNA) are listed on the NASDAQ and all prices are listed in US Dollars. Verona Pharma employs 25 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Verona Pharma
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VRNA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Verona Pharma stock price (NASDAQ: VRNA)Use our graph to track the performance of VRNA stocks over time.
Verona Pharma shares at a glance
|Latest market close||$5.82|
|52-week range||$5.40 - $9.72|
|50-day moving average||$6.31|
|200-day moving average||$7.38|
|Wall St. target price||$19.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.34|
Buy Verona Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Verona Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Verona Pharma price performance over time
|1 week (2021-07-25)||N/A|
|1 month (2021-07-02)||-2.51%|
|3 months (2021-05-05)||-7.77%|
|6 months (2021-02-01)||N/A|
|1 year (2020-08-01)||N/A|
|2 years (2019-08-01)||N/A|
|3 years (2018-08-01)||N/A|
|5 years (2016-08-01)||N/A|
Verona Pharma financials
|Gross profit TTM||$0|
|Return on assets TTM||-37.8%|
|Return on equity TTM||-72.44%|
|Market capitalisation||$347.7 million|
TTM: trailing 12 months
Shorting Verona Pharma shares
There are currently 206,475 Verona Pharma shares held short by investors – that's known as Verona Pharma's "short interest". This figure is 12.6% down from 236,166 last month.
There are a few different ways that this level of interest in shorting Verona Pharma shares can be evaluated.
Verona Pharma's "short interest ratio" (SIR)
Verona Pharma's "short interest ratio" (SIR) is the quantity of Verona Pharma shares currently shorted divided by the average quantity of Verona Pharma shares traded daily (recently around 62758.358662614). Verona Pharma's SIR currently stands at 3.29. In other words for every 100,000 Verona Pharma shares traded daily on the market, roughly 3290 shares are currently held short.
However Verona Pharma's short interest can also be evaluated against the total number of Verona Pharma shares, or, against the total number of tradable Verona Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Verona Pharma's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Verona Pharma shares in existence, roughly 0 shares are currently held short) or 0.0063% of the tradable shares (for every 100,000 tradable Verona Pharma shares, roughly 6 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Verona Pharma.
Find out more about how you can short Verona Pharma stock.
Verona Pharma share dividends
We're not expecting Verona Pharma to pay a dividend over the next 12 months.
Verona Pharma share price volatility
Over the last 12 months, Verona Pharma's shares have ranged in value from as little as $5.4 up to $9.722. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma's is 0.5145. This would suggest that Verona Pharma's shares are less volatile than average (for this exchange).
Verona Pharma overview
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 2 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. It also focuses on developing ensifentrine for the treatment of COVID-19. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom. .
Verona Pharma in the news
Verona Pharma Announces August 2021 Virtual Investor Conference Participation
Verona Pharma Announces August 2021 Virtual Investor Conference Participation
Verona Pharma to Report Second Quarter 2021 Financial Results and Provide Corporate Update
Frequently asked questionsWhat percentage of Verona Pharma is owned by insiders or institutions?
Currently 10.377% of Verona Pharma shares are held by insiders and 64.897% by institutions. How many people work for Verona Pharma?
Latest data suggests 25 work at Verona Pharma. When does the fiscal year end for Verona Pharma?
Verona Pharma's fiscal year ends in December. Where is Verona Pharma based?
Verona Pharma's address is: 3 More London Riverside, London, United Kingdom, SE1 2RE What is Verona Pharma's ISIN number?
Verona Pharma's international securities identification number is: US9250501064 What is Verona Pharma's CUSIP number?
Verona Pharma's Committee on Uniform Securities Identification Procedures number is: 925050106
More guides on Finder
How to buy Chobani stock when it goes public
Everything we know about the Chobani IPO, plus information on how to buy in.
How to buy Stronghold Digital Mining (SDIG) stock when it goes public
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
How to buy ROX Financial LP (ROXA) stock when it goes public
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
Ask an Expert